AHR and neuroblastoma: The next step involved the evaluation of EDA as a novel AHR agonist by docking and molecular dynamics simulations using an AHR 3D structure, the analysis of AHR nuclear translocation and AHR target gene expression in the human neuroblastoma cell line SH-SY5Y and zebrafish larvae.